Great Eastern (G07) · Insurance
Great Eastern Q3 2026 earnings: summary, key numbers & outlook
Results filed 2 Nov 2026 · Quarter ended 30 Sep 2026
Press release ↗Investor relations ↗
Summaries and transcripts are machine-generated and can contain errors.
In brief
Great Eastern completed the partial sale of its Indonesian subsidiary GELI to OCBC Indonesia on 1 September 2026, ceding control to meet local regulatory requirements.
The main change this quarter was in structure. Great Eastern completed the partial divestment of PT Great Eastern Life Indonesia (GELI) to OCBC Indonesia, so it no longer controls that business. Elsewhere, demand held up. Singapore drove growth in new sales, helped by higher volumes and a more favourable product mix. Malaysia kept growing, but more slowly, in subdued market conditions.
Management says the underlying business remains strong. It also expects the investment outlook to stay challenging in the near-to-medium term. The tension is that growth is concentrated in Singapore, where sales moderated in the third quarter. Malaysia faces weaker conditions and medical claims pressure, and Indonesia now sits outside the group's control.
No call transcript for this quarter, so this summary also draws on: RecordOwl News ↗.
Key numbers
| Segment or metric | Value | Change |
|---|---|---|
| Group TWNS (9M-26) | 9% | grew year-on-year, with Singapore the main contributor |
| Singapore TWNS (9M-26) | 11% | grew year-on-year, with some moderation in the third quarter |
| Malaysia TWNS (3Q-26) | 3% | 4% in 9M-26 |
Where each number comes from
- Group TWNS (9M-26): “The Group’s TWNS for 9M-26 grew 9% year-on-year, with Singapore being the main contributor to growth.”
- Singapore TWNS (9M-26): “Singapore TWNS grew 11% year-on-year in 9M-26, reflecting continued growth momentum, notwithstanding some moderation in the third quarter.”
- Malaysia TWNS (3Q-26): “Malaysia continued to record TWNS growth, increasing 3% year-on-year in 3Q-26 and 4% in 9M-26, amid more subdued market conditions.”
Copied from the press release ↗ and other documents in the company's results page ↗. A figure is published only if its sentence is in those documents.
Key takeaways
Indonesian subsidiary sold down to meet local rules
The partial divestment of GELI to OCBC Indonesia closed on 1 September 2026 to comply with local regulatory requirements. The Group ceased to have control over GELI, which changes its footprint in Indonesia.
Singapore remains the main growth engine
Singapore was the main contributor to Group sales growth, with TWNS up 11% year-on-year in 9M-26. Growth moderated in the third quarter, so momentum there is worth watching.
Product mix lifted new business profitability
NBEV, which measures the long-term profitability of new sales, grew strongly and outpaced TWNS growth. Management credits higher sales volumes and a more favourable product mix, mainly in Singapore.
Malaysia grows slowly amid subdued conditions
Malaysia TWNS rose 3% in 3Q-26 and 4% in 9M-26 in more subdued market conditions. Claims pressures in the Malaysia medical business also weighed on insurance profit.
Management expects a challenging investment backdrop
Higher interest rates in 3Q-26 produced mark-to-market losses on the fixed-income portfolio, and the group said the investment outlook is likely to stay challenging near to medium term. It maintains that underlying business fundamentals are strong.
Questions
What happened with Great Eastern's Indonesian business?
Great Eastern completed the partial divestment of PT Great Eastern Life Indonesia (GELI) to OCBC Indonesia on 1 September 2026 to comply with local regulatory requirements. It ceased to have control over GELI as a result.
Where is Great Eastern's sales growth coming from?
Singapore is the main contributor, with TWNS up 11% year-on-year in 9M-26, although growth moderated in the third quarter. Group TWNS grew 9% over the nine months.
Is Great Eastern selling higher-value business?
Evidence points that way. NBEV grew strongly and outpaced TWNS growth, which Great Eastern attributes to higher sales volumes and a more favourable product mix, led by Singapore.
How is the Malaysia business performing?
Malaysia kept growing, with TWNS up 3% in 3Q-26 and 4% in 9M-26, and NBEV growth at a more moderate pace amid subdued market conditions. Claims pressures in the Malaysia medical business weighed on insurance profit.
What is management's outlook on investments?
The group said the investment outlook is likely to stay challenging in the near-to-medium term. Higher interest rates caused mark-to-market losses on fixed-income holdings in 3Q-26, though management says underlying fundamentals remain strong.
Documents
Results documents